Chemical Formula: C11H21N3O4

Chemical Formula C11H21N3O4

Found 81 metabolite its formula value is C11H21N3O4

Isoleucyl-Glutamine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-4-(C-hydroxycarbonimidoyl)butanoate

C11H21N3O4 (259.1532)


Isoleucyl-Glutamine is a dipeptide composed of isoleucine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Glutaminylisoleucine

(2S,3S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-methylpentanoate

C11H21N3O4 (259.1532)


Glutaminylisoleucine is a dipeptide composed of glutamine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaminylleucine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-4-methylpentanoate

C11H21N3O4 (259.1532)


Glutaminylleucine is a dipeptide composed of glutamine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Hydroxyprolyl-Lysine

6-Amino-2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}hexanoate

C11H21N3O4 (259.1532)


Hydroxyprolyl-Lysine is a dipeptide composed of hydroxyproline and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Isoleucyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-methylpentanoyl)-C-hydroxycarbonimidoyl]butanoate

C11H21N3O4 (259.1532)


Isoleucyl-Gamma-glutamate is a dipeptide composed of isoleucine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Leucyl-Glutamine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-4-(C-hydroxycarbonimidoyl)butanoate

C11H21N3O4 (259.1532)


Leucyl-Glutamine is a dipeptide composed of leucine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Leucyl-Gamma-glutamate

2-Amino-4-[(2-amino-4-methylpentanoyl)-C-hydroxycarbonimidoyl]butanoate

C11H21N3O4 (259.1532)


Leucyl-Gamma-glutamate is a dipeptide composed of leucine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Lysylhydroxyproline

(2S,4R)-1-[(2S)-2,6-diaminohexanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C11H21N3O4 (259.1532)


Lysylhydroxyproline is a dipeptide composed of lysine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Val Ala Ala|Val-Ala-Ala

Val Ala Ala|Val-Ala-Ala

C11H21N3O4 (259.1532)


   

SCHEMBL18613512

2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]propanoic acid

C11H21N3O4 (259.1532)


   
   
   
   
   
   

SCHEMBL16710453

2-[[2-[(2-amino-5-methylhexanoyl)amino]acetyl]amino]acetic acid

C11H21N3O4 (259.1532)


   
   
   
   
   

isoleucylglutamine

isoleucylglutamine

C11H21N3O4 (259.1532)


Annotation level-2

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

GLN-Ile

2-(2-amino-3-methylpentanamido)-4-carbamoylbutanoic acid

C11H21N3O4 (259.1532)


   

GLN-Leu

2-(2-amino-4-methylpentanamido)-4-carbamoylbutanoic acid

C11H21N3O4 (259.1532)


   

Hpro-lys

1-(2,6-diaminohexanoyl)-4-hydroxypyrrolidine-2-carboxylic acid

C11H21N3O4 (259.1532)


   

Ile-GLN

2-(2-amino-4-carbamoylbutanamido)-3-methylpentanoic acid

C11H21N3O4 (259.1532)


A dipeptide formed from L-isoleucine and L-glutamine residues.

   

Ile-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-methylpentanoic acid

C11H21N3O4 (259.1532)


   

Leu-GLN

2-(2-amino-4-carbamoylbutanamido)-4-methylpentanoic acid

C11H21N3O4 (259.1532)


   

Leu-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-4-methylpentanoic acid

C11H21N3O4 (259.1532)


   

Lys-hpro

6-amino-2-[(4-hydroxypyrrolidin-2-yl)formamido]hexanoic acid

C11H21N3O4 (259.1532)


   

GGlu-Ile

2-(2-amino-3-methylpentanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C11H21N3O4 (259.1532)


   

GGlu-Leu

2-(2-amino-4-methylpentanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C11H21N3O4 (259.1532)


   

N,N-DI-BOC-GUANIDINE

N,N-DI-BOC-GUANIDINE

C11H21N3O4 (259.1532)


   

H-GLY-DL-LEU-DL-ALA-OH

H-GLY-DL-LEU-DL-ALA-OH

C11H21N3O4 (259.1532)


   

H-DL-Ala-DL-Leu-Gly-OH

H-DL-Ala-DL-Leu-Gly-OH

C11H21N3O4 (259.1532)


   

Glycyl-alanyl-leucine

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-4-methylpentanoic acid

C11H21N3O4 (259.1532)


   

Leu-Ala-Gly

Leu-Ala-Gly

C11H21N3O4 (259.1532)


A tripeptide composed of L-leucine, L-alanine and glycine joined in sequence by peptide linkages.

   

Glycyl-alanyl-isoleucine

(2S,3S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-3-methylpentanoic acid

C11H21N3O4 (259.1532)


   

Leucyl-Glutamine

Leucyl-Glutamine

C11H21N3O4 (259.1532)


   
   

Glycine, L-alanyl-L-leucyl-

Glycine, L-alanyl-L-leucyl-

C11H21N3O4 (259.1532)


   

L-Alanine, glycyl-L-leucyl-

L-Alanine, glycyl-L-leucyl-

C11H21N3O4 (259.1532)


   

(Tert-butyloxycarbonyl)-alanyl-alanyl-amine

(Tert-butyloxycarbonyl)-alanyl-alanyl-amine

C11H21N3O4 (259.1532)


   

(Tert-butyloxycarbonyl)-alanyl-amino ethyl-formamide

(Tert-butyloxycarbonyl)-alanyl-amino ethyl-formamide

C11H21N3O4 (259.1532)


   

(2S)-5-amino-2-[[(2S,3S)-2-azaniumyl-3-methylpentanoyl]amino]-5-oxopentanoate

(2S)-5-amino-2-[[(2S,3S)-2-azaniumyl-3-methylpentanoyl]amino]-5-oxopentanoate

C11H21N3O4 (259.1532)


   

Lysyl-hydroxyproline

Lysyl-hydroxyproline

C11H21N3O4 (259.1532)


   
   
   
   
   
   
   
   
   
   

L-Glutaminyl-L-leucine

L-Glutaminyl-L-leucine

C11H21N3O4 (259.1532)


   

L-Glutaminyl-L-isoleucine

L-Glutaminyl-L-isoleucine

C11H21N3O4 (259.1532)


   

Hydroxyprolyl-Lysine

Hydroxyprolyl-Lysine

C11H21N3O4 (259.1532)


   

Leucyl-Gamma-glutamate

Leucyl-Gamma-glutamate

C11H21N3O4 (259.1532)


   

Isoleucyl-Gamma-glutamate

Isoleucyl-Gamma-glutamate

C11H21N3O4 (259.1532)


   

glutaminylisoleucine

glutaminylisoleucine

C11H21N3O4 (259.1532)


   
   
   

Gly-Ala-Ile

(2S,3S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-3-methylpentanoic acid

C11H21N3O4 (259.1532)


   

Gly-Ala-Leu

(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]propanoyl]amino]-4-methylpentanoic acid

C11H21N3O4 (259.1532)


   
   

{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxypropylidene]amino}acetic acid

{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxypropylidene]amino}acetic acid

C11H21N3O4 (259.1532)